Effects of new healthcare reform on pharmaceutical supply system of China
YAN Shu XU Dongzi OUYANG Zhaolian
Department of Strategic Intelligence Research on Medical Device and Drug, Institute of Medical Information & Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100020, China
Abstract：A series of policies and measures on pharmaceutical research and development, production and distribution are released and carried out under China′s ongoing new healthcare reform, which have brought profound effects on pharmaceutical supply system. This paper classifies and studies recent key documents, measures and achievements of the reform, which are aimed to advance pharmaceutical supply system in three categories. It is found that these policies and measures have provided benefits to the pharmaceutical supply system in many aspects including innovation stimulating, production capability raising and distribution environment optimizing. However, new challenges may appear since the reform has entered the “deep water zone”, suggestions that the reform should pay more attention to policies implementation and enhance policy coherence, establish reform assessment process, reinforce the coordination of medical care, medical insurance and pharmaceutical industry and construct compensation rules, as well as improve the ability to foresight and respond to the new problems are given.
严舒 徐东紫 欧阳昭连. 新医改对我国药品供应保障的影响[J]. 中国医药导报, 2018, 15(35): 142-145.
YAN Shu XU Dongzi OUYANG Zhaolian. Effects of new healthcare reform on pharmaceutical supply system of China. 中国医药导报, 2018, 15(35): 142-145.
2018, Vol. 15 
京公网安备 11010502046598号